CRISPR Therapeutics
Gene editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform.
Multinational United States
Team
0
Confidence
12/100
About
Gene editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform.
Links
Admin
Last Update
Sep 16, 2024
Missing
funding stage, product stage, sector, founding year, founding month, number of employees, tags, invite member, business model, address, description, video or image, funding rounds, news, markets, external profiles, not claimed
Internal
Created by
Ortal Wein (ortalw@sncentral.org)
Created
2024-09-16T00:00:00.000Z
Recent activity
Ortal Wein · Manual · 2024-09-16 15:09:11.000000
Ortal Wein · Automatic · 2024-09-16 15:09:11.000000
Ortal Wein · Automatic · 2024-09-16 15:09:11.000000